Cancer Genetics

You have full text access to this OnlineOpen article

Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

  1. Hanna Tuhkanen1,2,3,
  2. Maarit Anttila1,3,
  3. Veli-Matti Kosma1,4,
  4. Seppo Heinonen3,
  5. Matti Juhola5,
  6. Seppo Helisalmi6,
  7. Vesa Kataja2,
  8. Arto Mannermaa1,4,7,†,*

Article first published online: 26 APR 2006

DOI: 10.1002/ijc.21785

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 6, pages 1345–1353, 15 September 2006

Additional Information

How to Cite

Tuhkanen, H., Anttila, M., Kosma, V.-M., Heinonen, S., Juhola, M., Helisalmi, S., Kataja, V. and Mannermaa, A. (2006), Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas. Int. J. Cancer, 119: 1345–1353. doi: 10.1002/ijc.21785

Author Information

  1. 1

    Department of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  2. 2

    Department of Oncology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  3. 3

    Department of Obstetrics and Gynecology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  4. 4

    Department of Pathology, Center for Laboratory Medicine, University of Tampere and Tampere University Hospital, Tampere, Finland

  5. 5

    Department of Pathology, Jyväskylä Central Hospital, Jyväskylä, Finland

  6. 6

    Department of Neurology and Neurosciences, Brain Research Unit, Clinical Research Center/Mediteknia, University of Kuopio, Kuopio, Finland

  7. 7

    Department of Clinical Genetics, University of Oulu and Oulu University Hospital, Oulu, Finland

  1. †

    Fax: +358-17-162753.

*Department of Pathology and Forensic Medicine, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland

Publication History

  1. Issue published online: 7 JUL 2006
  2. Article first published online: 26 APR 2006
  3. Manuscript Accepted: 29 NOV 2005
  4. Manuscript Received: 29 JUN 2005

Funded by

  • Special Government Funding of Kuopio and Tampere University Hospitals (EVO)
  • Finnish Cancer Foundation
  • Cancer Fund of North Savo
  • Finnish Medical Foundation
  • Finnish Cultural Foundation
  • University Foundation of Kuopio

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (236K)

References

  • 1
    Tlsty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11: 54–9.
  • 2
    Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332–7.
  • 3
    Mueller MM, Fusenig NE. Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839–49.
  • 4
    Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17–32.
  • 5
    Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004; 117: 1495–502.
  • 6
    Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848–51.
  • 7
    Tuhkanen H, Anttila M, Kosma VM, Ylä-Herttuala S, Heinonen S, Kuronen A, Juhola M, Tammi R, Tammi M, Mannermaa A. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 2004; 109: 247–52.
    Direct Link:
  • 8
    Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000; 60: 2562–6.
  • 9
    Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001; 10: 1907–13.
  • 10
    Wernert N, Locherbach C, Wellmann A, Behrens P, Hugel A. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 2001; 21: 2259–64.
  • 11
    Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002; 32: 355–7.
  • 12
    Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal cells. Cancer Res 2004; 64: 7231–6.
  • 13
    Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
  • 14
    Anttila MA, Tammi RH, Tammi MI, Syrjänen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000; 60: 150–5.
  • 15
    Serov SF, Scully R, Sobin LH. International histological classification of tumors, no. 9: histological typing of ovarian tumors. Geneva: WHO, 1973.
  • 16
    Karjalainen JM, Kellokoski JK, Mannermaa AJ, Kujala HE, Moisio KI, Mitchell PJ, Eskelinen MJ, Alhava EM, Kosma VM. Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2α in cutaneous melanoma. Br J Cancer 2000; 82: 2015–21.
  • 17
    Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004; 566: 9–20.
  • 18
    Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 2004; 103: 2892–9.
  • 19
    Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–54.
  • 20
    Kalluri R, Neilson EG. Epithelial–mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776–84.
  • 21
    Thiery JP. Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740–6.
  • 22
    Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, Bissell MJ, Rønnov-Jessen L. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 2003; 162: 391–402.
  • 23
    Weber F, Shen L, Sweet K, Cooper K, Morrison CD, Caldes T, Eng C. Genome wide analysis of allelic imbalance in tumor epithelium and stromal in patients with BRCA1 and BRCA2 mutation positive hereditary breast cancer. In: Annual Meeting 2005, Salt Lake City, Utah, October 25–29, 2005. The American Society of Human Genetics, Abstract 231.
  • 24
    Zborovskaya I, Gasparian A, Karseladze A, Elcheva I, Trofimova E, Driouch K, Trassard M, Tatosyan A, Lidereau R. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity. Int J Cancer 1999; 82: 822–6.
    Direct Link:
  • 25
    Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res 2002; 62: 3466–76.
  • 26
    Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AM, Brown PO. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002; 99: 12963–8.
  • 27
    Masayesva BG, Ha P, Garrett-Mayer E, Pilkington T, Mao R, Prevsner J, Speed T, Benoi N, Moon CS, Sidransky D, Westra WH, Califano J. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. Proc Natl Acad Sci USA 2004; 101: 8715–20.
  • 28
    Postma C, Hermsen MAJA, Coffa J, Baak JPA, Mueller JD, Mueller E, Bethke B, Schouten JP, Stolte M, Meijer GA. Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 2005; 205: 514–21.
    Direct Link:
  • 29
    Wang ZR, Liu W, Smith ST, Parrish RS, Young SR. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp Mol Pathol 1999; 66: 140–8.
  • 30
    Fujita M, Enomoto T, Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol 2003; 202: 97–9.
  • 31
    Lassus H, Leminen A, Vayrynen A, Cheng G, Gustafsson JS, Isola J, Butzow R. ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma. Gynecol Oncol 2004; 92: 31–9.
View Full Article (HTML) Get PDF (236K)